Option Care Health, Inc. $OPCH Shares Acquired by Livforsakringsbolaget Skandia Omsesidigt

Livforsakringsbolaget Skandia Omsesidigt grew its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 22.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 147,400 shares of the company’s stock after purchasing an additional 27,500 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt owned approximately 0.09% of Option Care Health worth $4,007,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in OPCH. V Square Quantitative Management LLC acquired a new stake in Option Care Health during the fourth quarter valued at $25,000. McIlrath & Eck LLC acquired a new position in shares of Option Care Health in the second quarter worth about $37,000. Advisory Services Network LLC acquired a new position in shares of Option Care Health in the third quarter worth about $35,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Option Care Health in the third quarter worth about $38,000. Finally, Employees Retirement System of Texas purchased a new stake in shares of Option Care Health during the 4th quarter worth about $45,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 36,610 shares of Option Care Health stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average cost of $21.41 per share, with a total value of $783,820.10. Following the purchase, the director owned 450,000 shares in the company, valued at $9,634,500. This trade represents a 8.86% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO John Charles Rademacher acquired 12,500 shares of Option Care Health stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average cost of $21.18 per share, with a total value of $264,750.00. Following the completion of the purchase, the chief executive officer owned 695,152 shares in the company, valued at $14,723,319.36. The trade was a 1.83% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought a total of 73,264 shares of company stock worth $1,548,316 over the last quarter. 1.70% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on OPCH. UBS Group restated a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th. Stephens set a $30.00 price target on Option Care Health in a research report on Friday, May 1st. TD Cowen dropped their price objective on Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a report on Friday, May 1st. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price objective for the company. in a research report on Friday, May 1st. Finally, Morgan Stanley set a $28.00 target price on Option Care Health in a research note on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $30.54.

Option Care Health Stock Down 1.6%

OPCH opened at $21.35 on Wednesday. Option Care Health, Inc. has a twelve month low of $18.01 and a twelve month high of $36.80. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. The company has a 50-day moving average price of $21.06 and a 200 day moving average price of $27.68. The company has a market cap of $3.35 billion, a PE ratio of 16.55, a price-to-earnings-growth ratio of 1.21 and a beta of 0.65.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. During the same period last year, the company posted $0.40 EPS. Option Care Health’s quarterly revenue was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Sell-side analysts expect that Option Care Health, Inc. will post 1.64 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.